Ptc Therapeutics PTCT
NASDAQ PTCT
$64.91 +0.77 (+1.20%)
At close: Nov 11, 2026 · 4:00 PM EST

Ptc Therapeutics (PTCT) Return on Sales [ROS] (2012 - 2026)

Updated

Ptc Therapeutics' Return on Sales [ROS] was 7.02% in Q3 2026, up 5.59 percentage points from 1.43% a year earlier but down 34.30 percentage points from the prior quarter.

Analysis

Ptc Therapeutics (PTCT) Return on Sales [ROS] (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ptc Therapeutics' Return on Sales [ROS] was 12.78% through Sep 30, 2026, down 30.83 percentage points year-over-year; for FY2025, it was 50.09%, up 87.60 percentage points from FY2024.

  • Return on Sales [ROS] has now increased for five consecutive years, with a five-year change of +163.49 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -37.50% in FY2024 (+9.36 pp), -46.86% in FY2023 (+17.16 pp), -64.03% in FY2022 (+5.50 pp) and -69.52% in FY2021 (+43.87 pp).
  • Quarterly Return on Sales [ROS] has moved between -119.67% (Q4 2022) and 82.50% (Q1 2025) over five years.
  • Compared with a year earlier, Return on Sales [ROS] was higher in six of the last eight quarters, with an average year-over-year change of +11.31 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2023 (a gain of 121.56 percentage points); the worst was Q4 2024 (a drop of 78.07 percentage points).
  • Per Business Quant data, PTCT's Return on Sales [ROS] in the three quarters before Q3 2026 was 41.32% (Q2 2026), 16.50% (Q1 2026) and -43.33% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Ptc Therapeutics 5.36 Bn -2.84 Bn 334.14 Mn 7.02%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 7.02%
Jun 30, 2026 41.32%
Mar 31, 2026 16.50%
Dec 31, 2025 -43.33%
Sep 30, 2025 1.43%
Jun 30, 2025 -19.54%
Mar 31, 2025 82.50%
Dec 31, 2024 -76.18%
Sep 30, 2024 -27.70%
Jun 30, 2024 -21.54%
Mar 31, 2024 -21.63%
Dec 31, 2023 1.90%
Sep 30, 2023 -60.11%
Jun 30, 2023 -98.01%
Mar 31, 2023 -53.37%
Dec 31, 2022 -119.67%
Sep 30, 2022 -31.40%
Jun 30, 2022 -55.80%
Mar 31, 2022 -58.17%
Dec 31, 2021 -51.28%
API Access

Ptc Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PTCT&period=max&api_key=YOUR_API_KEY